Pfizer, Moderna to file FDA COVID-19 vaccine emergency usage as soon as Friday

Advertisement

BEGIN ARTICLE PREVIEW:

BioNTech co-founder and CEO Dr. Ugur Sahin provides insight into the vaccine progress with Pfizer. Pfizer and partner BioNTech confirmed they will seek approval from the Food and Drug Administration on Friday for emergency usage of their new COVID-19 vaccine, a major step forward in a fight against a pandemic that has killed more people in the U.S. than any other nation.Continue Reading Below”Hope and help are on the way,” Health and Human Services Secretary Alex Azar, a point person in the Trump administration’s push to develop a safeguard against the disease, said the night before.“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally,” Dr. Albert Bourla, Pfizer Chairman and CEO, said in a statement.”Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” he added.TickerSecurityLastChangeChange %MRNAMODERNA INC.97.54+4.77+5.14%PFEPFIZER INC.36.70+0.48+1.34%Pfizer and BioNTech are currently in Phase 3 trials on …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE